Publicerad: 2024-05-13
Nya diagnoser
PIDcare är nu uppdaterat med 57 nya diagnoser.
Dessa är:
MajorCategory | Subcategory | Diagnosis | Gene | ICD10 |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 1 T-B+ SCID | PAX1 deficiency | PAX1 | D81.2 |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 1 T-B+ SCID | SLP76 deficiency | SLP76 | D81.2 |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 1 T-B+ SCID | ITPKB deficiency | ITPKB | D81.2 |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency | MAN2B2 deficiency | MAN2B2 | D81.9 |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency | SASH3 deficiency | SASH3 | |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency | CHUK deficiency | CHUK | |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency | IKK alfa deficiency | IKZF2 | |
1 Immunodeficiencies affecting cellular and humoral immunity | 1 - Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency | COPG1 deficiency | COPG1 | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 2 DNA Repair Defects other than those listed in Table 1 | MCM10 deficiency | MCM10 | D81.9 |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 5 Hyper IgE Syndromes (HIES) | IL6 signal transducer (IL6DT) deficiency (partial) | IL6ST | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 5 Hyper IgE Syndromes (HIES) | IL6ST deficiency (partial) | IL6ST | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 8 Calcium Channel Defects | CRACR2A deficiency | CRACR2A | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 9 Other Combined immunodeficiencies wwith syndromic features | DIAPH1 deficiency | DIAPH1 | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 9 Other Combined immunodeficiencies wwith syndromic features | AIOLOS deficiency | IKZF3 | |
2 Combined immunodeficiencies with associated or syndromic features | 2 - Subtable 9 Other Combined immunodeficiencies wwith syndromic features | CD28 deficiency | CD28 | |
3 Predominantly Antibody Deficiencies | 3 - Subtable 1 Agammaglobulinemia | FNIP1 deficiency | FNIP1 | D80.0 |
3 Predominantly Antibody Deficiencies | 3 - Subtable 1 Agammaglobulinemia | Pu.1 deficiency | SPI1 | |
3 Predominantly Antibody Deficiencies | 3 - Subtable 2 CVID Phenotype | PIK3CG deficiency | PIK3CG | D83.9 |
3 Predominantly Antibody Deficiencies | 3 - Subtable 2 CVID Phenotype | POU2AF1 deficiency | POU2AF1 | |
3 Predominantly Antibody Deficiencies | 3 - Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM | CTNNBL1 deficiency | CTNNBL1 | D80.5 |
3 Predominantly Antibody Deficiencies | 3 - Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM | TNFSF13 (APRIL) deficiency | TNFSF13 | D80.5 |
4 Diseases of Immune Dysregulation | 4 - Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes) | RHOG deficiency | RHOG | |
4 Diseases of Immune Dysregulation | 4 - Subtable 2 FHL Syndromes with Hypopigmentation | CEBPE neofunction | CEBPE | |
4 Diseases of Immune Dysregulation | 4 - Subtable 3 Regulatory T Cell Defects | IKZF1 GOF | IKZF1 | D81.8 |
4 Diseases of Immune Dysregulation | 4 - Subtable 4 Autoimmunity with or without Lymphoproliferation | PD1 deficiency | PDCD1 | |
4 Diseases of Immune Dysregulation | 4 - Subtable 4 Autoimmunity with or without Lymphoproliferation | SOCS1 deficiency | SOCS1 | D81.8 |
4 Diseases of Immune Dysregulation | 4 - Subtable 5 Immune Dysregulation with Colitis | ELF4 deficiency | ELF4 | |
4 Diseases of Immune Dysregulation | 4 - Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions | TET2 deficiency | TET2 | D82.3 |
5 Congenital defects of phagocyte number or function | 5 - Subtable 1 Congenital Neutropenias | CXCR2 deficiency | CXCR2 | |
6 Defects in intrinsic and innate immunity | 6 - Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD) | TBX21 deficiency | TBX21 | D72 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD) | IFN gamma deficiency | IFNG | D72 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 3 Predisposition to Severe Viral Infection | ZNFX1 deficiency | ZNFX1 | |
6 Defects in intrinsic and innate immunity | 6 - Subtable 3 Predisposition to Severe Viral Infection | NOS2 deficiency | NOS2 | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility | TLR7 deficiency | TLR7 | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 4 Herpes Simplex Encephalitis (HSE) | MAP1LC3B2 | MAP1LC3B2 | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 4 Herpes Simplex Encephalitis (HSE) | ATG4A | ATG4A | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 4 Herpes Simplex Encephalitis (HSE) | SNORA31 deficiency | SNORA31 | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 6 Predisposition to Mucocutaneous Candidiasis | MAPK8 deficiency | MAPK8 | D89.9 |
6 Defects in intrinsic and innate immunity | 6 - Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility | TLR8 GOF | TLR8 | |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | ATAD3A deficiency | ATAD3A | |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | CDC42 defects | CDC42 | D89.9 |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | LSM11 deficiency | LSM11 | D89.9 |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | STING-like disease | TMEM173 | |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | C2orf69 deficiency | C2orf69 | |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | RNU7-1 deficiency | RNU7-1 | D89.9 |
7 Autoinflammatory Disorders | 7 - Subtable 1 Type 1 Interferonopathies | STAT2 R148 LOF/regulation (prevents binding to USP18) | STAT2 | D89.9 |
7 Autoinflammatory Disorders | 7 - Subtable 2 Defects Affecting the Inflammasome | RIPK1 deficiency | RIPK1 | |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | HCK disease | HCK | |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | HEM1 (NCKAPIL) deficiency | NCKAPIL | K52.3 |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | PRAAS -like condition | PSMB9 | |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | TBK1 disorder | TBK1 | M04.8 |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | NEMO-NDAS | IKBKG | M04.8 |
7 Autoinflammatory Disorders | 7 - Subtable 3 Non-Inflammasome Related Conditions | SYK disease | SYK | |
9 Bone marrow failure | 9 | EVI1, MECOM deficiency | MECOM | |
10 Phenocopies of PID | 10 - Subtable 1 Associated with somatic mutations | VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome | Somatic mutation in UBA1 (XL) | D89.9 |
10 Phenocopies of PID | 10 - Subtable 1 Associated with somatic mutations | TLR8 GOF | Somatic mutation in TLR8 | D89.9 |
10 Phenocopies of PID | 10 - Subtable 2 Associated with autoantibodies | Severe Covid-19 | AutoAb to type 1 IFNs (IFN alfa, IFN omega) | D89.9 |